Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical ­Pro-Arteriosclerotic Inflammatory Response

Da Liu; Wilson Y. Szeto; Krzysztof Laudanski

doi:10.12659/MSM.937934

13 January 2023: Clinical Research

Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical Pro-Arteriosclerotic Inflammatory Response

Da Liu ^1BE , Wilson Y. Szeto ^2E , Krzysztof Laudanski ^3ACDE*

DOI: 10.12659/MSM.937934

Med Sci Monit 2023; 29:e937934

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 1 Biomarker levels after surgery.Biomarker levels were measured with RT-PCR from patient blood samples taken at baseline (pre-surgery), 24 hours after surgery, 7 days after surgery, and 3 months after surgery. Biomarker levels are presented as mean±SD. (A) RANKL, (B) BMP-2, (C) FGF-23. * P<0.05. SD – standard deviation.

Back to the Article

Your Privacy